Flyer

International Journal of Drug Development and Research

  • ISSN: 0975-9344
  • Journal h-index: 49
  • Journal CiteScore: 11.20
  • Journal Impact Factor: 8.24
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Publons
  • MIAR
  • University Grants Commission
  • Euro Pub
  • Google Scholar
  • J-Gate
  • SHERPA ROMEO
  • Secret Search Engine Labs
  • ResearchGate
  • International Committee of Medical Journal Editors (ICMJE)
Share This Page

David Ross

Bio analytical Core Group, Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer Global Research and Development, USA

Publications
  • Mini Review   
    Drug Development for Cancer Treatment
    Author(s): David Ross*

    To provide the RNA and protein complexity needed to control gene expression, RNA editing is essential. Correct RNA editing preserves organism development and cell function. Diseases and cancer may result from an imbalance in the RNA editing machinery. Though few studies have been reported in the realm of natural products that target RNA editing for disease and cancer therapy, it has recently been acknowledged as a target for drug discovery. Therefore, medicinal natural compounds may be able to target RNA editing. We present a literature summary of the biological effects of RNA editing on gene expression, illnesses, malignancies, and medications in this study. Additionally, a summary of the RNA editing bioinformatics resources was provided. Keywords Drug discovery; Drug Development; Cancer therapy; RNA editing; Bioinformatics .. View More»

    DOI: 10.36648-0975-9344-15.1-990

    Abstract HTML PDF